Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the ...
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and ...
How to get tickets and presale for Joan Jett and the Blackhearts’ Glasgow show this summer. Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website ...
Lenny Kravitz has announced a huge show at London’s Gunnersbury Park this summer – buy tickets here. The pre-sale begins on Wednesday (February 4) from 10am and you can sign up here, while O2 Priority ...
Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...
CraftyCrafty.tv today announced the continued expansion of its Tutorials section. SC, UNITED STATES, January 13, 2026 /EINPresswire.com/ — CraftyCrafty.tv today ...
The MarketWatch News Department was not involved in the creation of this content. -- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is ...
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (AXSM), a biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results